Jansen, A. G. et al. Psychiatric polygenic risk scores as predictor for attention deficit/hyperactivity disorder and autism spectrum disorder in a clinical child and adolescent sample. Behav. Genet. 50, 203–212 (2020).
Qi, X. et al. Integrating genome-wide association study and methylation functional annotation data identified candidate genes and pathways for schizophrenia. Progr. Neuropsychopharmacol. Biol. Psychiatry https://doi.org/10.1016/j.pnpbp.2019.109736 (2019).
Johansson, V. et al. A population-based heritability estimate of bipolar disorder—in a Swedish twin sample. Psychiatry Res. 278, 180–187 (2019).
Otte, C. et al. Major depressive disorder. Nat. Rev. Dis. Prim. 2, 16065 (2016).
Wittchen, H. U. et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 21, 655–679 (2011).
Baio, J. et al. Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveill. Summ. 67, 1–23 (2018).
Felt, B. T. et al. Diagnosis and management of ADHD in children. Am. Fam. Physician 90, 456–464 (2014).
Kieling, C. et al. The age at onset of attention deficit hyperactivity disorder. Am. J. Psychiatry 167, 14–16 (2010).
Karpov, B. et al. Anxiety symptoms in a major mood and schizophrenia spectrum disorders. Eur Psychiatry 37, 1–7 (2016).
Selzam, S. et al. A polygenic p factor for major psychiatric disorders. Transl. Psychiatry 8, 205 (2018).
Doherty, J. L. & Owen, M. J. Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Med. 6, 29 (2014).
Power, R. A. et al. Genome-wide association for major depression through age at onset stratification: major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Biol. psychiatry 81, 325–335 (2017).
Faraone, S. V. & Larsson, H. Genetics of attention deficit hyperactivity disorder. Mol. Psychiatry 24, 562–575 (2019).
Corfield, E. C., Yang, Y., Martin, N. G. & Nyholt, D. R. A continuum of genetic liability for minor and major depression. Transl. Psychiatry 7, e1131 (2017).
Sandin, S. et al. The heritability of autism spectrum disorder. J. Am. Med. Assoc. 318, 1182–1184 (2017).
Nordsletten, A. E. et al. Evaluating the impact of nonrandom mating: psychiatric outcomes among the offspring of pairs diagnosed with schizophrenia and bipolar disorder. Biol. Psychiatry 87, 253–262 (2020).
Sullivan, P. F., Neale, M. C. & Kendler, K. S. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157, 1552–1562 (2000).
McGuffin, P. et al. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch. Gen. Psychiatry 60, 497–502 (2003).
Edvardsen, J. et al. Heritability of bipolar spectrum disorders. Unity or heterogeneity? J. Affect. Disord. 106, 229–240 (2008).
Cardno, A. G. & Gottesman, I. I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 97, 12–17 (2000).
Lam, M. et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat. Genet. 51, 1670–1678 (2019).
Pardinas, A. F. et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 50, 381–389 (2018).
Stahl, E. A. et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat. Genet. 51, 793–803 (2019).
Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).
Demontis, D. et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 51, 63–75 (2019).
Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431–444 (2019).
Howard, D. M. et al. Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways. Nat. Commun. 9, 1470 (2018).
Cross-Disorder Group of the Psychiatric Genomics C. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371–1379 (2013).
Cross-Disorder Group of the Psychiatric Genomics Consortium. Electronic address p.m.h.e. and Cross-Disorder Group of the Psychiatric Genomics C. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell 179, 1469–1482. e1411 (2019).
Howard, D. M. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343–352 (2019).
Ripke, S. et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014).
Turley, P. et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat. Genet. 50, 229–237 (2018).
The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68 (2015).
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005–D1012 (2019).
Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369–375. s361–s363 (2012).
Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501 (2016).
Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).
Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
Wang, D. et al. Comprehensive functional genomic resource and integrative model for the human brain. Science. 362, https://doi.org/10.1126/science.aat8464 (2018).
Ramasamy, A. et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat. Neurosci. 17, 1418–1428 (2014).
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
Schmitt, A. D. et al. A compendium of chromatin contact maps reveals spatially active regions in the human genome. Cell Rep. 17, 2042–2059 (2016).
Ward, L. D. & Kellis, M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930–D934 (2012).
Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739–1740 (2011).
Kang, H. J. et al. Spatio-temporal transcriptome of the human brain. Nature 478, 483–489 (2011).
Loh, P. R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443–1448 (2016).
Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016).
Bigdeli, T. B. et al. A simple yet accurate correction for winner’s curse can predict signals discovered in much larger genome scans. Bioinformatics 32, 2598–2603 (2016).
Davies, G. et al. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat. Commun. 9, 2098 (2018).
Okbay, A. et al. Genome-wide association study identifies 74 loci associated with educational attainment. Nature 533, 539–542 (2016).
Hill, W. D. et al. A combined analysis of genetically correlated traits identifies 187 loci and a role for neurogenesis and myelination in intelligence. Mol. Psychiatry 24, 169–181 (2019).
Potkin, S. G. et al. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr. Bull. 35, 96–108 (2009).
Nicita, F. et al. Heterozygous missense variants of SPTBN2 are a frequent cause of congenital cerebellar ataxia. Clin. Genet. 96, 169–175 (2019).
Wang, X., Christian, K. M., Song, H. & Ming, G. L. Synaptic dysfunction in complex psychiatric disorders: from genetics to mechanisms. Genome Med. 10, 9 (2018).
Lam, M. et al. Pleiotropic meta-analysis of cognition, education, and schizophrenia differentiates roles of early neurodevelopmental and adult synaptic pathways. Am. J. Hum. Genet. 105, 334–350 (2019).
Elia, J. et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol. Psychiatry 15, 637–646 (2010).
Devon, R. S. et al. The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia. Mol. Psychiatry 6, 311–314 (2001).
Matosin, N., Fernandez-Enright, F., Lum, J. S. & Newell, K. A. Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment. Neuropharmacology 115, 73–91 (2017).
Xu, J., Zhu, Y., Contractor, A. & Heinemann, S. F. mGluR5 has a critical role in inhibitory learning. J. Neurosci. 29, 3676–3684 (2009).
Lu, Y. M. et al. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J. Neurosci. 17, 5196–5205 (1997).
Zou, D., Huang, J., Wu, X. & Li, L. Metabotropic glutamate subtype 5 receptors modulate fear-conditioning induced enhancement of prepulse inhibition in rats. Neuropharmacology 52, 476–486 (2007).
Vales, K. et al. The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801. Eur. J. Pharmacol. 639, 91–98 (2010).
Akkus, F. et al. Metabotropic glutamate receptor 5 neuroimaging in schizophrenia. Schizophr. Res. 183, 95–101 (2017).
Kumar, A., Dhull, D. K. & Mishra, P. S. Therapeutic potential of mGluR5 targeting in Alzheimer’s disease. Front. Neurosci. 9, 215 (2015).
Luthi-Carter, R., Barczak, A. K., Speno, H. & Coyle, J. T. Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II. Brain Res. 795, 341–348 (1998).
Devlin, A. M. et al. Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum. Mol. Genet. 9, 2837–2844 (2000).
Roffman, J. L. et al. Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia. Schizophr. Bull. 39, 330–338 (2013).
Kirkbride, J. B. et al. Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects? Epigenomics 4, 303–315 (2012).
Glessner, J. T. et al. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc. Natl Acad. Sci. USA 107, 10584–10589 (2010).
Stopkova, P. et al. Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia. Biol. Psychiatry 55, 981–988 (2004).
Saito, T., Aghalar, M. R. & Lachman, H. M. Analysis of PIK3C3 promoter variant in African-Americans with schizophrenia. Schizophr. Res. 76, 361–362 (2005).
Wong, C. C. et al. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol. Psychiatry 19, 495–503 (2014).
Bult, C. J. et al. Mouse Genome Database (MGD) 2019. Nucleic Acids Res. 47, D801–D806 (2019).
Nagel, M. et al. Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways. Nat. Genet. 50, 920–927 (2018).
Baselmans, B. M. L. et al. Multivariate genome-wide analyses of the well-being spectrum. Nat. Genet. 51, 445–451 (2019).
Lee, J. J. et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat. Genet. 50, 1112–1121 (2018).
Raychaudhuri, S. et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet. 40, 1216–1223 (2008).
Beecham, A. H. et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353–1360 (2013).
Chen, J. M. et al. The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus. BMC Genet. 16, 121 (2015).
Tan, J., Town, T. & Mullan, M. CD40-CD40L interaction in Alzheimer’s disease. Curr. Opin. Pharmacol. 2, 445–451 (2002).
Carriba P. & Davies A. M. CD40 is a major regulator of dendrite growth from developing excitatory and inhibitory neurons. eLife 6, https://doi.org/10.7554/eLife.30442 (2017).
Halbach, M. V. et al. Atxn2 knockout and CAG42-knock-in cerebellum shows similarly dysregulated expression in calcium homeostasis pathway. Cerebellum 16, 68–81 (2017).
Richetto, J. et al. Genome-wide transcriptional profiling and structural magnetic resonance imaging in the maternal immune activation model of neurodevelopmental disorders. Cereb. Cortex. 27, 3397–3413 (2017).
O’Connell, K. S. et al. Identification of genetic overlap and novel risk loci for attention-deficit/hyperactivity disorder and bipolar disorder. Molecular Psychiatry https://doi.org/10.1038/s41380-019-0613-z (2019).
Ikeda, Y. et al. Spectrin mutations cause spinocerebellar ataxia type 5. Nat. Genet. 38, 184–190 (2006).
Tiosano, S. et al. Schizophrenia among patients with systemic lupus erythematosus: population-based cross-sectional study. Epidemiol. Psychiatr. Sci. 26, 424–429 (2017).
Estes, M. L. & McAllister, A. K. Maternal immune activation: Implications for neuropsychiatric disorders. Science 353, 772–777 (2016).
Kendall, K. M. et al. Association of rare copy number variants with risk of depression. Association of rare copy number variants with risk of depression. JAMA Psychiatry 76, 818–825 (2019).
Warland, A. et al. Schizophrenia-associated genomic copy number variants and subcortical brain volumes in the UK Biobank. Mol. Psychiatry 25, 854–862 (2020).